Skip to main content
logo
Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURX · Real-Time Price · USD
4.710
-0.560 (-10.63%)
At close: Aug 21, 2026

Curanex Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
79---
Market Cap Growth
-----
Enterprise Value
54---
Last Close Price
4.716.61---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
1.400.84---
P/TBV Ratio
1.540.84---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.060.03---
Net Debt / Equity Ratio
-0.56-0.41-0.30-1.24-0.24
Quick Ratio
28.1736.2910.225.21-
Current Ratio
45.9581.9435.545.21-
Return on Equity (ROE)
-411.08%-72.09%-128.32%-54.60%-
Return on Assets (ROA)
-225.06%-43.80%-61.28%-28.51%-
Return on Capital Employed (ROCE)
-212.30%-37.00%-57.70%-32.10%-197.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-141.72%-45.09%---
Buyback Yield / Dilution
-15.03%-92.30%-2109.84%--
SEC Filings: 10-K · 10-Q